DANYELZA (Naxitamab)

**Product type:** Human Prescription Drug

**Active ingredient:** NAXITAMAB

**Strength:** 40 mg/10mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Y-mAbs Therapeutics, Inc.

**Marketing category:** BLA (BLA761171)

**Pharmacologic class:** Glycolipid Disialoganglioside-directed Antibody Interactions [MoA], Glycolipid Disialoganglioside-directed Antibody [EPC]